Cancer BiologybioRxiv
Overcoming Tumor Heterogeneity by Ex Vivo Arming of T Cells Using Multiple Bispecific Antibodies
This study evaluates multi-antigen targeting strategies using bispecific antibodies to enhance T cell immunotherapy against heterogeneous tumors, showing improved efficacy and reduced cytokine release.
DOI 10.1136/jitc-2021-003771